The FRATER-RAZES pharmacovigilance department aims to promote the rational use of our medicines; to propose measures to reduce the risks and severity of adverse effects linked to the use of all FRATER-RAZES products and to improve information on risk and its prevention, in order to guarantee patient safety.
Nous assurons le recueil, l’identification, l’évaluation, et la prévention des risques liées à l’utilisations des produits FRATER-RAZES.
Nous sommes en relation permanente avec le Centre national de pharmacovigilance et de matériovigilance (CNPM) dont les missions sont assurées conformément aux réglementations nationales.
To report any adverse event on a Frater Razès laboratory specialty, contact us by:
Founded by Doctor Abdelhamid Cherfaoui, the FRATER-RAZES Laboratories group is one of the first laboratories to invest in the pharmaceutical market in Algeria.
© 2024 FRATER RAZES, All rights reserved.